| Home  | About ScienceAsia  | Publication charge  | Advertise with us  | Subscription for printed version  | Contact us  
Editorial Board
Journal Policy
Instructions for Authors
Online submission
Author Login
Reviewer Login
Volume 52 Number 4
Volume 52 Number 3
Volume 52 Number 2
Volume 52 Number 1
Volume 51 Number 6
Volume 51S Number 2
Earlier issues
Volume 49 Number 3


Research articles

ScienceAsia 52 (2026): 1-7 |doi: 10.2306/scienceasia1513-1874.2026.078


Mechanisms underlying taurine protection against copper sulfate-induced toxicity and inflammation in zebrafish


Chenlin Yua,b,*, Tiantian Chena

 
ABSTRACT:     This study investigates the protective effects of taurine (TAU) against copper sulfate (CuSO4 )-induced toxicity and inflammation in zebrafish. Zebrafish larvae were exposed to various concentrations of TAU and CuSO4 , followed by assessments of morphological changes, survival rates, oxidative stress, inflammatory responses, and programmed cell death. Results demonstrate that TAU significantly reduced CuSO4-induced mortality and morphological abnormalities, with a mortality rate of 13.3% in the TAU-treated group compared to 83.3% in the CuSO4 only group. Additionally, TAU treatment down-regulated the expression of oxidative stress and inflammation-related genes, including hsp70 and cox-2, and decreased levels of pro-inflammatory mediator genes such as nf-?b, tnf-?, il-1?, and il-6. Furthermore, TAU effectively reduced the apoptosis rate in zebrafish larvae by inhibiting the pro-apoptotic gene bax. These findings highlight the potential of TAU as a therapeutic agent for protecting aquatic organisms from heavy metal toxicity via its antioxidant and anti-inflammatory mechanisms.

Download PDF

Downloads Views


a Collaborative Innovation Center for Biomedicine, Shanghai University of Medicine and Health Sciences, Shanghai 201318 China
b School of Pharmacy, Shanghai University of Medicine and Health Sciences, Shanghai 201318 China

* Corresponding author, E-mail: ycl0408@163.com

Received 23 Jul 2025, Accepted 6 Aug 2026